Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical-trial record for the daratumumab-plus-VRd study in newly diagnosed multiple myeloma is available, with its study details, participant criteria, treatment plan, locations, and reported outcomes. The page also includes trial publications and study documents.
    Difference
    74%
    Check dated 2026-11-08T05:23:16.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T02:56:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notice above the 403 error page announces NIH website updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T03:08:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T02:54:05.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T03:54:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record details, indicating that access to the trial information at this URL is blocked.
    Difference
    21%
    Check dated 2026-09-20T02:05:13.000Z thumbnail image

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.